An in-vitro assay using human spermatozoa to detect toxicity of biologically active substances

Tino Vollmer,Börje Ljungberg,Vera Jankowski,Joachim Jankowski,Griet Glorieux,Bernd G. Stegmayr
DOI: https://doi.org/10.1038/s41598-019-50929-z
IF: 4.6
2019-10-10
Scientific Reports
Abstract:Abstract Identifying the key toxic players within an in-vivo toxic syndrome is crucial to develop targeted therapies. Here, we established a novel method that characterizes the effect of single substances by means of an ex-vivo incubation set-up. We found that primary human spermatozoa elicit a distinct motile response on a (uremic) toxic milieu. Specifically, this approach describes the influence of a bulk toxic environment (uremia) as well as single substances (uremic toxins) by real-time analyzing motile cellular behavior. We established the human spermatozoa-based toxicity testing (HSTT) for detecting single substance-induced toxicity to be used as a screening tool to identify in-vivo toxins. Further, we propose an application of the HSTT as a method of clinical use to evaluate toxin-removing interventions (hemodialysis).
multidisciplinary sciences
What problem does this paper attempt to address?